ACB $8.307 (-3.52%)

ACNNF $0.265 (0.04%)

AERO $1.160 (-13.43%)

AGEEF $0.540 (1.94%)

ALEAF $1.220 (-0.8%)

AMMJ $0.337 (2.12%)

APHA $6.480 (-3.86%)

ARNA $53.930 (-1.23%)

ATT:CNX $0.080 (0%)

ATTBF $0.032 (-11.2%)

AUSA:CNX $1.080 (-2.7%)

AUSAF $0.840 (-4.55%)

AVXL $3.595 (-2.84%)

BAMM:CNX $2.220 (0%)

BBM:CNX $0.550 (-1.79%)

BBRRF $0.421 (-7.17%)

BE:CNX $0.095 (5.56%)

BIO:CNX $0.590 (0%)

BLEVF $0.068 (-0.12%)

BLIS:CNX $0.410 (-4.65%)

BLO:CNX $1.150 (0%)

BLOZF $0.874 (-1.58%)

BUDZ $0.713 (-2.4%)

BXNG $0.535 (8.08%)

CADMF $1.456 (3.26%)

CALI:CNX $0.125 (0%)

CANN $1.640 (4.46%)

CARA $18.950 (-0.26%)

CBII:CNX $0.265 (-1.85%)

CBWTF $0.620 (0.38%)

CGC $44.307 (-3.72%)

CGRW $0.545 (0.93%)

CHOO:CNX $0.480 (-2.04%)

CHOOF $0.369 (-2.84%)

CNAB $0.420 (10.24%)

CNBX $0.300 (-4.9%)

CNGGF $1.560 (-0.95%)

CODI $16.350 (-0.55%)

CPMD $1.830 (4.57%)

CRBP $7.310 (-1.22%)

CRON $16.130 (3.4%)

CROP:CNX $0.270 (-1.82%)

CRXPF $0.201 (-4.29%)

CSI:CNX $1.860 (-5.1%)

CTST $5.653 (-4.19%)

CURR $4.000 (0%)

CVSI $4.700 (1.51%)

CWEB:CNX $20.000 (-4.53%)

DIGP $0.154 (1.89%)

DXBRF $0.812 (10.33%)

EAPH $0.008 (-1.23%)

EAT:CNX $0.225 (2.27%)

EEVVF $0.282 (-3.17%)

EMHTF $2.780 (1.83%)

EPWCF $0.140 (11.92%)

EVIO $0.390 (-2.5%)

FFRMF $0.085 (0%)

FFT:CNX $0.115 (0%)

FNNZF $0.089 (-13.29%)

FSDDF $0.179 (2.05%)

GGTTF $0.459 (3.45%)

GLDFF $0.078 (0%)

GLH:CNX $0.105 (0%)

GLNNF $0.112 (-0.71%)

GNBT $1.020 (-7.26%)

GRIN:CNX $0.290 (3.57%)

GRWG $3.380 (-0.29%)

GTBIF $11.529 (-3.56%)

GTII:CNX $15.700 (1.68%)

GWPH $187.210 (1.74%)

HC:CNX $0.305 (0%)

HEXO $6.580 (-4.5%)

HHPHF $0.228 (-6.82%)

HLSPY $0.586 (22.49%)

HMLSF $15.191 (1.1%)

HMPPF $0.735 (0.07%)

HRVOF $0.600 (0.15%)

HSTRF $0.328 (0.95%)

HUGE:CNX $0.225 (-2.17%)

IAN:CNX $5.320 (-2.74%)

IGC $1.050 (-6.25%)

IGXT $0.510 (0%)

IIPR $86.790 (-0.71%)

IMLFF $0.320 (-1.16%)

INQD $0.020 (-9.09%)

INSY $0.870 (-3.87%)

IONC:CNX $0.420 (-4.55%)

ISOL:CNX $1.100 (5.77%)

ISOLF $0.790 (2.73%)

ITHUF $4.080 (-0.46%)

IVITF $0.385 (-1.33%)

JWCAF $0.638 (-4.14%)

KALTF $0.036 (-6.48%)

KBEV:CNX $0.400 (-4.76%)

KBEVF $0.313 (-0.53%)

KHRNF $2.410 (-0.41%)

KSHB $4.870 (-0.61%)

LDS:CNX $0.420 (-2.33%)

LDSYF $0.333 (-10%)

LHS:CNX $0.740 (0%)

LHSIF $0.560 (2.75%)

LIHT:CNX $0.200 (0%)

LIHTF $0.147 (-4.92%)

LOVE:CNX $0.170 (-2.86%)

LVWL:CNX $0.740 (0%)

LXLLF $0.751 (-25.64%)

LXRP $0.960 (-2.86%)

LXX:CNX $1.220 (-3.17%)

MCIG $0.069 (1.32%)

MDCL $3.160 (5.69%)

MEDIF $5.195 (0.87%)

MGWFF $0.105 (-8.7%)

MICWF $0.255 (-1.54%)

MJ:CNX $0.475 (-3.06%)

MJNA $0.072 (14.77%)

MNTR $0.340 (-2.86%)

MRRCF $0.700 (21.72%)

MWM:CNX $0.335 (-1.47%)

MYM:CNX $0.455 (-2.15%)

MYMMF $0.353 (-1.51%)

NCNNF $0.829 (-3.63%)

NDVAF $0.385 (3.19%)

NGW:CNX $0.385 (-2.53%)

NRXCF $0.060 (1.69%)

NSPDF $0.089 (-6.2%)

NTEC $5.130 (4.06%)

NVTQF $0.017 (7.98%)

NWKRF $0.420 (-4.93%)

NXGWF $0.290 (-9.38%)

NXTTF $0.646 (16.78%)

OH:CNX $11.090 (-2.29%)

ORHOF $8.427 (0.62%)

OWCP $0.032 (45.66%)

PHGI:CNX $0.465 (-3.13%)

PHGRF $0.357 (-2.39%)

PHVAF $0.460 (-5.95%)

PILL:CNX $0.750 (-6.25%)

PKG:CNX $0.240 (0%)

PLPRF $3.652 (0.43%)

PLUS:CNX $4.780 (-2.65%)

PMCB $0.039 (0%)

PNPL $0.980 (-2%)

POTN $0.095 (-12.52%)

PRCNF $0.100 (-16.67%)

PTNYF $0.185 (1.59%)

PUFXF $0.382 (4.66%)

QCA:CNX $0.220 (4.76%)

RDDTF $0.732 (-3.56%)

RLLVF $0.082 (-0.12%)

RMHB $0.083 (3.75%)

RQB:CNX $0.650 (1.56%)

RQHTF $0.165 (1.69%)

RVVQF $0.480 (4.35%)

SLNG:CNX $2.190 (0.46%)

SMG $88.300 (-1.21%)

SNN:CNX $4.120 (-2.14%)

SNNVF $3.110 (-0.46%)

SOL:CNX $2.300 (-3.36%)

SOLCF $1.780 (-1.2%)

SPLIF $0.169 (0.77%)

SPRWF $1.390 (-1.63%)

SRNA $0.044 (-2%)

STEM:CNX $2.250 (0%)

STMH $1.600 (-3.03%)

SUN:CNX $0.690 (-1.43%)

TBPMF $0.457 (1.37%)

TCAN:CNX $5.740 (-6.21%)

TDRYF $0.309 (0%)

TER:CNX $7.790 (-2.26%)

TGEN $3.400 (-0.87%)

TGIF:CNX $0.450 (0%)

TGIFF $0.339 (7.42%)

THC:CNX $0.290 (5.45%)

THCBF $0.205 (0.99%)

TLRY $46.240 (3.72%)

TOKI:CNX $0.150 (0%)

TRLFF $0.365 (-3.21%)

TRPX $3.300 (-1.49%)

TRSSF $5.916 (-0.41%)

TRTC $0.740 (-3.27%)

TURV $0.540 (-1.19%)

VBIO $0.220 (4.76%)

VIDA:CNX $0.590 (-6.35%)

VIN:CNX $0.520 (0%)

VPRB $0.065 (8.33%)

VRNDF $1.051 (-2.69%)

VRT:CNX $0.510 (0%)

VRTHF $0.376 (-3.22%)

VVCIF $0.515 (3.46%)

WAYL:CNX $0.740 (0%)

WDDMF $1.300 (-1.52%)

WLDFF $0.529 (2.16%)

XXII $2.085 (0.26%)

ZDPY $0.310 (-0.64%)

ZYNE $14.660 (-1.08%)

Technical420 Site Search

Returned 36 result(s).

Chemesis Has Been Nothing Short of an Execution Story In 2019

Earlier this month, we highlighted Chemesis International (CSI.CN) (CADMF) and we hope that you put this opportunity on your radar. Since the last update, the company has been nothing short of an execution story and the shares have trending higher.The market responded favorably to Chemesis’ plan to add an additional…

Chemesis International Inc. to Expand Manufacturing Capacity in California

Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA) (the “Company” or “Chemesis”), announces plans to add an additional 25,000 ft2 of manufacturing, in Cathedral City, California. With the recent commercialization of its fully compliant state-of-the-art extraction facility, the Company is moving forward with this expansion plan and anticipates completion of the additional…

Chemesis International Inc. Acquires Intellectual Property for High-Quality Cannabis Extraction

Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA)w, announces it has acquired intellectual property ("IP") and the physical equipment for an extraction methodology to preserve all of the phytocannabinoids and terpenes from cannabis utilizing a low-temperature process to create "live resin". The method will allow the Company to produce a unique variety…

3 Emerging Market Cannabis Plays Investors Need To Know

During the last two years, the cannabis industry has experienced exponential growth and this is a trend that we expect to continue. A main driver of this growth has been the opening of new markets all over the world and these new markets represent emerging opportunities.The cannabis industry is a…

Chemesis International Inc. to Construct GMP Certified Extraction Facility & Production Lab in Bogota, Colombia

Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA), announces its wholly owned subsidiary La Finca Interacviva-Arachna Med (“La Finca”) plans to commence construction of its GMP certified extraction facility before the end of Q1, 2019. The state-of-the-art facility will also house a certified production lab, which will have a large production capacity for both domestic…

Chemesis International Inc. to Cultivate and Manufacture for Puerto Rican CBD Market

Chemesis International Inc. (CSE: CSI) (OTC: CADMF), announces its subsidiary Natural Ventures will enter the CBD market. The U.S. CBD market could surge to $845 million by 2019, and over $2 billion by 2022 [1] . With the passing of the 2018 Farm Bill the federal CBD market will allow U.S. territories…

Chemesis International Inc. Enters into Definitive Licensing Agreement to Manufacture Proprietary Patent Pending Dragonglass Flake and Bake™ THC Sublingual flake

Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA), announces its subsidiary Natural Ventures has entered into a licensing agreement to produce Dragonglass Flake and Bake™ (“Dragonglass”) for Project 1493 LLC., a subsidiary of GSRX Industries, Inc.  Dragonglass will be available exclusively at Green Spirit RX dispensaries throughout Puerto Rico.GSRX Industries Inc. (OTCQB: GSRX), one of Puerto Rico’s…

Chemesis International Is A 2019 Global Cannabis Story

2018 was a breakout year for the Latin American cannabis industry. The economics associated with the cultivation of cannabis in Latin America are attractive.In late 2018, we provided an update on Chemesis International (CSI.CN) (CADMF) that has been laser focused on the cannabis industry in North and South America and…

Chemesis International Inc. Announces Strategic Launch into the Beverage Industry

Chemesis International Inc. (CSE: CSI) (OTC: CADMF), through it’s subsidiary, Natural Ventures, announces the launch of its beverage division in Puerto Rico. Natural Ventures is a fully integrated medical cannabis company, with 100,000 ft2 of cultivation and 35,000 ft2 of manufacturing and extraction. Natural Ventures is currently servicing approximately 90%…

Chemesis International Inc. Closes Second Tranche of Financing for Total Proceeds of $1,750,000

Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA), announces that it has closed the previously announced debenture unit offering with strategic investors for aggregate gross proceeds to the Company of CDN $1,500,000.At the completion of the Offering, the Company issued 1,500 debenture units, each consisting of (a) one, unsecured,…

« Newer PostsOlder Posts »

Search Again